Thyroid hormones (THs, T4 and the transcriptionally active hormone T3) play an essential role in neurodevelopment; however, the mechanisms underlying T3 brain delivery during mice fetal development are not well known. This work has explored the sources of brain T3 during mice fetal development using biochemical, anatomical, and molecular approaches. The findings revealed that during late gestation, a large amount of fetal brain T4 is of maternal origin. Also, in the developing mouse brain, fetal T3 content is regulated through the conversion of T4 into T3 by type-2 deiodinase (D2) activity, which is present from earlier prenatal stages. Additionally, D2 activity was found to be essential to mediate expression of T3-dependent genes in the cerebral cortex, and also necessary to generate the transient cerebral cortex hyperthyroidism present in mice lacking the TH transporter Monocarboxylate transporter 8. Notably, the gene encoding for D2 (Dio2) was mainly expressed at the bloodcerebrospinal fluid barrier (BCSFB). Overall, these data signify that T4 deiodinated by D2 may be the only source of T3 during neocortical development. We therefore propose that D2 activity at the BCSFB converts the T4 transported across the choroid plexus into T3, thus supplying the brain with active hormone to maintain TH homeostasis
Introduction
The thyroid hormones (THs), 3,5,3′-triiodothyronine (T3) and thyroxine (T4), are essential for the correct development of vertebrates, controlling cell growth and metabolism in all tissues. The developing central nervous system (CNS) is particularly sensitive to TH deficiency as this leads to numerous alterations with different functional consequences depending on the timing and the cause for the deficit of TH Zoeller and Rovet 2004; .
Several regulatory mechanisms fine-tune the brain content of T4 and T3. These include their secretion by the thyroid gland, TH transport to the brain, activity of the deiodinases that are essential enzymes in TH metabolism, and in the fetus, transplacental passage of maternal THs (Obregon et al. 1984; Morreale de Escobar et al. 1990 ). The thyroid gland synthesizes mainly T4 although most TH actions are mediated by T3, the transcriptionally active form that modulates specific gene expression patterns (Brent 2012) . Of special relevance in the CNS is the monocarboxylate transporter 8 (MCT8), a TH-specific cell membrane transporter that is critical for normal TH function and action and for CNS development (Visser 2007; Fu et al. 2013; . Deiodinases (type-1, 2, and 3 or D1, D2, and D3) regulate local T3 and T4 availability (Gereben et al. 2008 ). D1 and D2 generate the transcriptionally active hormone T3 from T4 and in the cerebral cortex, D2 is the main deiodinase that generates T3 (Visser et al. 1982) . D3 deiodinates T4 and T3 producing transcriptionally inactive metabolites 3,5′,3′-triiodothyronine (rT3) and 3,3′-diodothyronine (T2), respectively.
The development of the cerebral cortex is extremely sensitive to TH. In humans, T3 and its receptor are already present in the cerebral cortex from the 10th week of gestation (Bernal and Pekonen 1984) . Both T3 and T3 receptor contents increase until the 20th week of gestation in parallel to an increase in D2 activity and T4 content (Kester et al. 2004 ). An appropriate delivery of TH to the cerebral cortex is essential for its correct development as seen in several studies in rodents, where hypothyroidism led to less defined cortical layering, neuronal migration, and differentiation defects (Berbel et al. 2014 ) and altered circuitry (Guadaño Ferraz et al. 1994 ) that ultimately interfere with the formation of cortical maps (Berbel et al. 1993; Lucio et al. 1997) . Furthermore, studies in primary mouse cerebrocortical cells cultures have revealed that T3 both induces the expression of genes related to differentiation and migration processes and also inhibits the expression of genes involved in mitosis, thereby allowing the transition from the embryonic to the adult cortex (Gil-Ibañez et al. 2015) . Moreover, many of the genes identified in this transcriptome analysis have been found to be critical regulators of cortical development as they encode proteins of the extracellular matrix or are expressed at the Cajal-Retzuis cells or at the subplate (Bernal 2016) .
For the juvenile and adult cerebral cortex, a model of T3 availability has been proposed (Guadaño-Ferraz et al. 1997) and validated. The model states that brain T3 has a double origin: 1) a fraction is available directly from the circulation with T3 crossing the brain barriers (including the blood-brain barrier, BBB, and the blood-cerebrospinal fluid barrier, BCSFB) mainly via the Mct8 transporter into the extracellular fluid where it directly reaches the neural cells or 2) T3 is produced locally by D2 activity from T4, which crosses the brain barriers through the organic anion transporter family member 1C1 (Oatp1c1) directly into the astrocytes . Each route contributes approximately 50% to the total pool of brain T3 in the juvenile and adult mouse brain (Dumitrescu et al. 2006; Galton et al. 2007; Trajkovic et al. 2007; Bárez-López et al. 2014) . In contrast, during fetal development, studies in rats suggest that the brain depends almost entirely on T3 locally generated by D2 activity Calvo et al. 1990) , despite the presence of the Mct8 transporter at the BBB (Grijota-Martínez et al. 2011) .
In the present study, we explored TH availability and action in mouse brain during fetal and perinatal development combining biochemical, anatomical, and molecular techniques. We characterized for the first time the expression of the gene encoding for D2 (Dio2) at an anatomical level in the developing fetal brain of rodents and we assessed the role of D2 activity during mouse fetal and early postnatal brain development with special focus on the cerebral cortex. Due to the crucial role of Mct8 transporter in TH availability in the cerebral cortex, the interaction between Mct8-dependent transport and D2 activity was also studied in different knock out (KO) mouse models. We now report that: 1) in the mouse, at least two-thirds of the total fetal T4 during late gestation are of maternal origin and maternal-fetal T3 transfer is restricted; 2) Dio2 mRNA and D2 activity are already present in the brain from earlier fetal stages; 3) the conversion of T4 into T3 by D2 activity may be the only source of T3 during mouse brain development; 4) T4 transport across the choroid plexus and conversion into T3 by D2 activity at the BCSFB may be key events in TH action in brain during embryonic development; 5) and that despite the substantial maternal T4 contribution to the total fetal T4 pool in maternal-fetal euthyroidism, the fetal brain triggers compensatory mechanisms to provide an appropriate content of T3 under low levels of maternal T4.
Materials and Methods

Ethics Statement
All experimental procedures involving animals were performed following the European Union Council guidelines (directive 2010/ 63/UE) and Spanish regulations (R.D. 53/2013), and were approved by the ethics committee at Consejo Superior de Investigaciones Científicas (CSIC; approval number 316/14). All efforts were made to minimize suffering, as indicated below.
Animal Models and Experimental Design
Animals were housed in temperature-and light-controlled conditions at 22 ± 2°C on a 12:12 light-dark cycle (lights on at 8 AM), and they had access to food and water ad libitum.
To analyze the relative effects of the maternal and the fetal thyroidal status, the following 3 groups were compared: 1) control euthyroid dams receiving no hormonal treatment; 2) dams treated with 1.5 μg T3/100 g body weight (BW) from E12, and 3) dams treated with 8 μg T4/100 g BW from E12. After mating with Wt male mice, Wt-treated pregnant dams were given only drinking water or either T3 or T4 in the drinking water from E12 until the end of the experiment on E18, the day prior to birth. The TH concentration was calculated on the basis of fluid intake to provide 1.5 μg T3/100 g BW or 8 μg T4/100 g BW in the drinking water containing 0.01% bovine serum albumin and was not corrected for increasing weight. On gestational day E18, dams were euthanized in a CO 2 euthanasia chamber and perfused with saline to remove blood from tissues before their collection. Prior to perfusion, blood was extracted by retroorbital collection rapidly after death and used for the determination of T4 and T3 plasma concentrations. In order to meet the weight of tissue required to determine TH content by radioimmunoassay (approximately 30 mg), analysis in fetal brain was performed in hemicerebra. Consequently, the rest of the studies at this stage were performed also in hemicerebra to obtain data from comparable situations. Embryos were euthanized by decapitation at E18 and their cerebra and livers were dissected out, blotted onto filter paper, frozen on dry ice, and stored at −80°C for T3 and T4 determinations, D2 activity assays, and gene expression analyses. For these tests, we used n = 7 independent fetuses coming from 7 different litters from Wt mothers receiving no hormonal treatments, n = 6 independent fetuses coming from 6 different litters from Wt mothers treated with T3, and n = 7 independent fetuses coming from 7 different litters from Wt mothers treated with T4.
To analyze the contribution of D2 activity at perinatal stages, different KO models were used. (Ceballos et al. 2009 ). Wt (n = 14) and Mct8KO (n = 14) littermates, Wt (n = 8) and Dio2KO (n = 8) littermates, and Dio2KO (n = 8) and Mct8/Dio2KO (n = 10) littermates at P3 were euthanized by decapitation and the cerebral cortices were dissected at 4°C in phosphate-buffered saline (phosphate buffer 0.05 M and 0.9% NaCl, pH 7.4). In order to obtain better insight into cerebral cortex development, and due to the small amount of tissue required to accomplish gene expression analyses and D2 activity determinations, studies on mice at P3 were performed in cerebral cortices. All tissue was blotted onto filter paper, frozen on dry ice, and stored at −80°C for gene expression analyses and D2 activity determinations. Histological studies were performed using at least 2 Wt animals at ages E15, E18, P1, and P3. The brains were fixed in 4% paraformaldehyde in 0.1 M PB for 24 h and embedded in paraffin. Blocks containing cerebral cortex were cut coronally into 8-μm-thick sections that were transferred onto Superfrost Ultra Plus slides (Thermo Scientific).
Hormonal Determinations in Plasma and Tissues
High specific activity 125 I -T3 and 125 I-T4 (3000 μCi/μg) were labeled with 125 I (Perkin Elmer, NEZ033A) using as substrates (3-5)-T2 (Sigma, D0629) and T3 (Sigma, T2877), respectively, according to Weeke and Orskov (1973) and Obregon et al. (1978) . The separation of the labeled products was modified using ascending paper chromatography for 16 h, in presence of Butanol:Ethanol:Ammonia 0.5N (5:1:2) as solvent. The 125 I -T3 and 125 I-T4 were eluted in Methanol:Ammonia 2N (9:1), evaporated to dryness and kept in Ethanol at 4°C.
For adult dams, individual 80 μL aliquots of plasma were extracted with Methanol (1:6), evaporated to dryness and taken up in the radioimmunoassay (RIA) buffer for determinations. For E18 mice, hemicerebra and livers from individual embryos were extracted for RIA determinations. T3 and T4 extraction from tissue, as well as determinations of T3 and T4, was performed as previously described (Morreale de Escobar et al. 1985; Ruiz de Oña et al. 1988 ) with the dynamic range being 0.4-100 pg T3/tube and 2.5-320 pg T4/tube. For both RIAs, the coefficients for intra-and interassay variation were 5% and 10-15%, respectively.
D2 Enzymatic Activity
D2 activity in the hemicerebra and hemicerebral cortices was measured as described by Obregon et al. (1989) with minor modifications. In brief, the release of 125 I iodide from 125 I-labeled substrates was measured in tissue homogenates using 0.32 M sucrose, 10 mM 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), and 10 mM dithiothreitol (DTT).
125
I-T4 was purified by removing contaminating iodide by paper electrophoresis. For D2 activity in hemicerebral cortex and hemicerebrum 125 I-T4 (100 000-50 000 cpm/tube), 2 nM T4 + 1 μM T3, 20 mM DTT, and 1 mM PTU were incubated for 60 min at 37°C using 50-150 μg protein/100 μL. The 125 I iodide released was directly measured in a gamma counter detector. The protein concentration was determined by the method of Lowry et al. (1951) after precipitation of the homogenates with 10% trichloroacetic acid to avoid interference from DTT in the colorimetric reaction.
Gene Expression
RNA was isolated from individual hemicerebra at E18 and hemicerebral cortices at P3. Total RNA was extracted using TRIZOL reagent (Invitrogen, 15596026) following the manufacturer's recommendations with an additional chloroform extraction. RNA quality control was performed with the Agilent 2100 Bioanalyzer. cDNA was prepared from 250 ng RNA using the high capacity cDNA reverse transcription kit (Applied Biosystems). For quantitative PCR (qPCR), a cDNA aliquot corresponding to 5 ng of the starting RNA was used. The real-time PCR was performed with the TaqMan universal PCR master mix, No Amp Erase UNG (Applied Biosystems), on a 7900HT fast real-time PCR system (Applied Biosystems). The PCR program consisted of a hot start of 95°C for 10 min, followed by 40 cycles of 15 s at 95°C and 1 min at 60°C. PCRs were performed in triplicates, using the 18S gene as internal standard and the 2-cycle threshold method for analysis. The expression of the following T3-dependent genes was measured using Applied Biosystems TaqMan probes: Dio2 (deiodinase type-2), Dio3 (deiodinase type-3), Hr (hairless), Klf9 (kruppel-like factor 9), Mct8 (solute carrier family 16, member 2), and Shh (sonic hedgehog). Data were expressed relative to the values obtained in tissues from the Wt mice in basal conditions (taken as 1.0) after correction for 18 S RNA.
In Situ Hybridization
In situ hybridization was performed as previously described (Bernal and Guadaño-Ferraz 2002) with minor modifications as a result of using paraffin-embedded tissue sections instead of freefloating sections. Briefly, Dio2 antisense and sense riboprobes were synthesized in the presence of 35 S-UTP from the D2 cDNA Rattus norvegicus template (NM_031720.4; spanning nucleotides 535-901) as described in Guadaño-Ferraz et al. (1997) . This sequence shares a 95% of similarity with Mus musculus. After deparaffination, hydration, and permeabilization, the sections were incubated with 9 × 10 6 cpm/500 μL of the labeled antisense riboprobes and sense riboprobes as negative controls overnight at 55°C in an oven. Nonspecific probe binding and excess probe were washed away in 50 mM Tris-HCl, pH 7.5, 5 mM EDTA, 0.5 M NaCl and 4 μg/mL RNase A (Sigma, 10109142001) and in buffers of decreasing saline citrate (SSC) concentrations at increasing temperatures up to 68°C. Sections were then dehydrated in ascending alcohols with NH 4 OAc 0.3 M and exposed to photographic film (BioMax, Kodak). After exposure for 60 days, the films were developed with Kodak D19 and fixed with fixative (Agfa, G354).
Nissl Staining
Sections were incubated for 15 min with 0.1% toluidine blue (Merk, 115930) . Then, they were dehydrated in ascending alcohols, cleared in xylenes, and covered with hydrophobic mounting medium Depex (Serva, 18243). Histological analyses were made with a Nikon Eclipse 80i microscope and photomicrographs were acquired with a Nikon DS-Fi1 digital camera.
Statistical Analysis
Differences between 2 groups were compared by 2-tailed unpaired Student's t-tests. Differences between means of 3 independent samples were done by one-way analysis of variance (ANOVA) and the Bonferroni's post hoc test to correct for multiple comparisons. In all cases, GraphPad software (www.graphpad.com) was used. Significant differences were represented as *P < 0.05; **P < 0.01 and ***P < 0.001.
Results
Sources of TH During Mice Fetal Development
The contribution of maternal T3 and T4 on fetal brain development was studied by treating euthyroid pregnant dams with either 1.5 μg of T3/100 g BW or 8 μg of T4/100 g BW in the drinking water from E12 to the day prior to birth E18. A main difference with previous studies in the rat GrijotaMartínez et al. 2011 ) is that in the present study in mice, a state of global hypothyroidism was not induced prior to hormone administration in order not to block fetal thyroid gland function by treating the mother with goitrogens. At E18, maternal plasma as well as fetal livers and cerebra were collected to assess the effects of the treatments. The following 3 groups were compared: untreated Wt dams and fetuses (euthyroid dams, Wt basal); T3-treated Wt dams and fetuses (euthyroid dams treated with T3, Wt + T3), and T4-treated Wt dams and fetuses (euthyroid dams treated with T4, Wt + T4). The outcome of hormonal treatment was checked by TH measurements in the dams and fetuses (Fig. 1) . The effects at the periphery were assessed by performing TH measurements in the dams' plasma. Considering the difficulties to obtain plasma samples from E18 fetuses, changes in TH concentrations in fetal livers after treatment were taken to evaluate TH transfer from the maternal side. Most probably, TH content in the fetal liver reflects TH levels in fetal plasma as is the case for rats (Hasen et al. 1968; DiStefano et al. 1982 ) and rat fetuses (Calvo et al. , 1992 Grijota-Martínez et al. 2011) . T3 treatment caused a 3-fold decrease in the maternal plasma T4 levels and increased T3 maternal plasma levels by 3.5-fold ( Fig. 1A,D ; Table 1 ). The decrease in maternal T4 levels after treatment with T3 was most probably due to TSH suppression and maybe due to changes in the clearance rate of T4. T4 treatment greatly increased T4 levels in maternal plasma and also increased plasma T3 to similar levels to that attained by T3 treatment (Fig. 1A,D ; Table 1 ).
In the fetal liver, T4 reflected the changes in maternal T4 plasma levels: fetal T4 content in the liver decreased or increased in parallel with changes in maternal T4 ( Fig. 1B; Table 1 ), but T3 remained unchanged despite the increase in maternal T3 levels ( Fig. 1E; Table 1 ). In the fetal brain, T4 content reflected the liver T4 status of the fetus: T3 treatment decreased the fetal liver T4 content by approximately 2.5-fold and by 2-fold the brain T4 content compared with the basal group and, on the other hand, T4 treatment induced a 6-fold increase in the fetal liver T4 content and a 1.85-fold increase in the brain T4 content compared with the basal group ( Fig. 1C; Table 1 ). Despite these variations in the T4 brain content, T3 content remained constant and close to normal control values ( Fig. 1F ; Table 1 ).
The mechanisms underlying the brain homeostasis in the content of T3 under a range of T4 content were explored. As D2 activity is highly regulated by T4 at the posttranslational level (Steinsapir et al. 1998; Gereben et al. 2000) , activity assays were performed in fetal brain to determine D2 activity under the different conditions. T3 treatment to the mothers resulted in a reduction of fetal brain T4 content and D2 activity was accordingly increased (Fig. 2A) . On the other hand, T4 treatment to the mothers led to a pronounced increase in the T4 fetal brain content and, under this condition, D2 activity was markedly inhibited (Fig. 2A) . Because D2 can also be regulated at the mRNA level (Croteau et al. 1996; Burmeister et al. 1997 ; Guadaño-Ferraz Data are expressed as means ± SE. **P < 0.01 and ***P < 0.001 were determined by one-way ANOVA and Bonferroni's post hoc test. et al. 1999), the expression of the gene encoding for D2 (Dio2) was studied by qPCR. Due to the relevant role of D3 in TH metabolism deiodinating T4 and T3 into biologically inactive metabolites, the expression of the gene encoding this protein (Dio3) was also assessed as Dio3 expression is known to correlate with D3 activity (Hernandez et al. 2012 ). The expression of Dio2 and Dio3 did not change in response to T3 or T4 treatments (Fig. 2B,C) . Expression of the TH transporters Mct8, Oatp1c1, and Lat2 was also studied by qPCR and no changes in the expression of the genes encoding for these transporters were detected in the brain of E18 fetuses after T3 or T4 treatments (data not shown).
Anatomical Localization of D2 in Mouse Brain Throughout Development
Due to the key role of D2 in preserving the T3 brain homeostasis during brain development, we analyzed Dio2 expression at a histological level. In the absence of reliable specific anti-D2 antibodies, Dio2 mRNA expression was analyzed by in situ hybridization at both fetal stages (E15 and E18) and early postnatal stages (P1 and P3) to characterize the expression pattern of Dio2 throughout development. Film autoradiograms from representative coronal sections at different brain levels are shown in Figure 3 along with the corresponding histological sections stained with Nissl. At E15, Dio2 mRNA expression was visible in the ependymal layer of the lateral ventricles (LVs) and the choroid plexus (chp). At E18, P1, and P3, Dio2 was additionally detected in the meninges (mng), striatum (CPu), lateral olfactory tract (LO) and upper layers of the cerebral cortex (I, II, III). At P1 and P3, Dio2 expression was now detected in the hippocampus, especially the dentate gyrus (DG), hippocampal fissure (hf) and median eminence (ME) resembling the already described Dio2 expression in rat at P15 (Guadaño-Ferraz et al. 1997 ).
Role of D2 During Early Cerebral Cortex Development
The contribution of D2 activity during the development of the cerebral cortex was further assessed using D2-deficient mice. Due to the relevant role of the Mct8 transporter in TH action in brain, the interaction between Mct8-dependent transport and D2 activity was also analyzed using double Mct8-and D2-deficient mice. Single Mct8KO mice present a state of brain hypothyroidism (Dumitrescu et al. 2006; Trajkovic et al. 2007) ; however, at perinatal stages of development these mice present a transient state of cerebral cortex hyperthyroidism (Ferrara et al. 2013 (Fig. 4) , Mct8KO animals displayed a state of brain hyperthyroidism with elevated expression levels of Hr and Shh in comparison with Wt animals as already described (Ferrara et al. 2013; Núñez et al. 2014 ). Dio2KO at P3 mice presented a state of brain hypothyroidism as the expression levels of Hr and Shh were decreased in comparison with Wt animals. The expression profiles of these T3-dependent genes in the double Mct8/Dio2KO were the same as in the single Dio2KO animals; hence Mct8/Dio2KO presented a state of brain hypothyroidism in comparison with Wt animals. Klf9 expression was not significantly regulated in any of the transgenic mice models. Expression of the gene encoding the TH transporter Mct8 did not change in the absence of D2 (Fig. 4) .
Finally, we assessed whether an elevated D2 activity in Mct8KO mice at P3 could be responsible for increasing T3 generation leading to local brain hyperthyroidism. D2 enzymatic activity assays revealed that at P3 D2 activity was not altered in the cerebral cortex of Mct8KO animals in comparison with Wt littermates (Fig. 5) . As previously described (Dumitrescu et al. 2006; Trajkovic et al. 2007 ), D2 activity in Mct8KO mice at P30 was remarkably increased in comparison with the Wt (Fig. 5) .
Discussion
THs play an essential role during the development and maturation of the cerebral cortex. A TH deficit causes irreversible damage (Guadaño Ferraz et al. 1994; Lucio et al. 1997 ) as some genes controlled by T3 (Gil-Ibañez et al. 2015) underlie critical events of cerebral cortex development (Bernal 2016) . Therefore, appropriate delivery of the transcriptionally active hormone T3 to the cerebral cortex is essential. Despite the fact that the mouse is currently the most widely used model to study TH action in brain, and that many transgenic models are being used to obtain insight into physiological and pathological conditions, the control of TH availability during mouse brain development has not been adequately studied. Here, we explored the physiological Figure 2 . Deiodinases in fetal brain. Effects of T3 and T4 treatment on D2 enzymatic activity (A) on the expression levels of Dio2 (B) and on the expression levels of Dio3 (C) in E18 fetal brains. Data are expressed as means ± SE. **P < 0.01 and ***P < 0.001 were determined by one-way ANOVA and Bonferroni's post hoc test.
mechanisms that control T3 delivery to target cells during perinatal stages of mouse brain development, with special focus on the contribution of maternal THs and fetal brain D2 activity, using biochemical, anatomical and molecular techniques.
Regarding maternal TH contribution to the fetus, a first conclusion is that during late gestation in the mouse, a large amount of fetal T4 including brain T4 is of maternal origin, and that maternal-fetal T3 transfer is restricted, possibly at the placental level. This is clearly evidenced by the decrease in the fetal liver T4 in fetuses coming from T3-treated dams, which reflects the reduction of circulating maternal T4. According to our data, a fraction of at least two-thirds of total liver T4 in the E18 mouse fetus is derived directly from the mother, whereas in the rat only about 17.5% of the fetal extra thyroidal T4 pool at term is of maternal origin ). When T4 is increased in the maternal plasma, T4 is consequently increased in the fetal liver, in agreement with previous findings that exogenously administered T4 in the dams can cross the placental barrier in mice (Dong et al. 2015) . By contrast, an increase in maternal T3 plasma levels had no effect on T3 content in fetal liver, probably due to the elevated D3 activity, which shows a strong preference for T3 (Sanders et al. 1999) , in the placenta (Bates et al. 1999; Santini et al. 1999) . Our findings contradict those in rats in which decreased levels of T4 in thyroidectomized dams did not result in decreased T4 content in fetal liver (Grijota-Martínez et al. 2011) . These discrepancies might be explained by the timing of thyroid gland development and the differences in the day of birth of both species. Although determinations in both rat and mouse were made the day prior to birth, in the experiments with rats determinations were made on E21, 4 days after onset of fetal thyroid function whereas in the current mouse experiments, determinations were made at E18, that is, 1.5 days after onset of fetal thyroid function. Therefore, the contribution of the fetal thyroid gland would be larger in rats than in mice, as observed in the present study. This reinforces the differences between mouse and rat models and the consequent need to describe TH economy during mice development. gave no signal. All sections were exposed for 60 days. I, II, III, superior layers of the cerebral cortex; chp, choroid plexus; CPu, caudate putamen (striatum); DG, dentate gyrus; hf, hippocampal fissure; LO, lateral olfactory tract; LV, lateral ventricles; ME, median eminence and mng, meninges. Scale bars 500 μm.
Regarding the fetal brain, a fraction of at least 50% of total brain T4 in the E18 mouse fetus derives from the mother, providing direct evidence that maternal T4 can cross fetal brain barriers. One of the most important findings currently was the maintenance of a euthyroid content of T3 in the brain despite pronounced changes in the content of brain T4. Accordingly, mRNA expression of the TH target genes Dio3 and Dio2 did not change at the transcriptional level. These results point to D2 activity as the main mechanism in maintaining T3 brain homeostasis since D2 enzymatic activity was present in mouse fetal brain from at least E18 and also highly responsive to brain T4 concentrations. In our experimental conditions, D2 was found to be regulated at the posttranslational level by T4 providing an essential source of T3 and avoiding variations in the intracerebral T3 content during mouse fetal development.
Remarkably, the current data suggest that although maternal T4 contributes enormously to the total fetal brain T4 pool, under the low levels of maternal T4 obtained after treatment with T3, the fetal brain is able to effectively trigger D2 activity as a regulatory mechanism to compensate for the lack of maternal T4. A previous study in mice demonstrated that administration of T4 to pregnant dams altered the expression of some T3-dependent genes in the cerebral cortex of E16 fetuses and that this transcriptionally response was potentiated in hypothyroxinemic brains, indicating that transient hypothyroxinemia triggers robust compensatory mechanisms (Dong et al. 2015) . We now identify D2 activity as a possible compensatory mechanism. Taking into RNA as means ± SE. **P < 0.01 and ***P < 0.001 were determined by 2-tailed unpaired Student's t-test using the respective controls for each case.
account the important role of D2 during rodent brain development, we explored the anatomical localization of D2. Interestingly, detection of Dio2 mRNA expression by in situ hybridization at E15 suggests a role for TH during early development before the onset of the fetal thyroid gland, which in mice is around E16.5 (Fernández et al. 2015) , highlighting the importance of transplacental TH transfer. At perinatal stages, Dio2 mRNA expression at the meninges, ependymal layer of LVs and choroid plexus suggests an important role of D2 activity in the local generation of T3 at the BCSFB. Dio2 mRNA expression at the BCSFB can have functional implications as at these stages the LVs represent a large fraction of the total brain volume (O'Rahilly and Müller 2008) and also, because the choroid plexus may have a greater transport capacity during early than later stages of brain growth and development (Keep and Jones 1990) . This suggests that during early brain development, T4 transport across the choroid plexus would be transformed into T3 by D2 activity at the BCSFB, and due to the large surface of the ventricles at perinatal stages; T3 from the CSF could reach the brain through the ventricles and access the neural cells to exert its action at a genomic level. In view of this, the contribution of the BCSFB to TH availability in the early developing brain would contrast with adult stages where TH availability to the brain is mainly through the BBB (Dratman et al. 1991) . In the adult brain, Dio2 is predominantly expressed in astrocytes throughout the brain and tanycytes (Guadaño-Ferraz et al. 1997; Tu et al. 1997) . In view of this, it is likely that during the development of the BBB (Obermeier et al. 2013 ) and before the maturation of astrocytes (Daneman et al. 2010) , D2 activity occurs mostly at the BCSFB.
The strong Dio2 mRNA expression in the striatum at prenatal stages of development, in comparison with other brain regions, suggests that D2 may already be generating T3 through T4 available from the systemic circulation in the striatum. Further experiments will be needed with higher resolution to obtain more information about the possible role of D2 in the development of this subcortical region. Furthermore, D2 activity at the meninges might have a critical role in mediating the development of the cerebral cortex. It is known that secretion of certain factors by the meninges, such as retinoic acid, BMP7, or the stromal-derived factor (SDF1), is essential for cortical neuron generation, migration, and correct distribution of neural cells during corticogenesis (Decimo et al. 2012 ). The meninges also produce molecular extracellular matrix components (Sievers et al. 1994) , which are essential for the development of the cerebral cortex (Beggs et al. 2003) . Based on present findings, we suggest that at perinatal stages, the generation of T3 by D2 activity at the meninges can be regulating the development of the cerebral cortex by controlling the synthesis of retinoid acid (Gil-Ibáñez et al. 2014) and regulating the expression of extracellular matrix components (Gil-Ibañez et al. 2015; Bernal 2016 ). Interestingly, recent neuroimaging studies on children born to mothers with clinical or subclinical hypothyroidism describe alterations in the thickness of several cortical regions with specific effects depending on the severity and timing of maternal TH insufficiency. These studies indicate that a deficit of TH during pregnancy has long-lasting effects on the cerebral cortex morphology in the offspring and evidence that a correct delivery of TH is essential for correct human corticogenesis (Lischinsky et al. 2016) . The contribution of D2 activity during mouse cerebral cortex development in regulating the supply of brain T3 was further evaluated by analyzing the expression of T3-dependent genes. Quantitative expression of T3-dependent genes is often used as an indicator of the thyroidal status of the cerebral cortex (Galton et al. 2007; Morte et al. 2010; Ferrara et al. 2013; Bárez-López et al. 2016) . Dio2KO animals at P3 showed a state of cerebral cortex hypothyroidism with reduced expression of T3-dependent genes. D2 deficiency did not trigger an increase in the expression of the gene encoding for Mct8 as a compensatory mechanism. The reduced expression of T3-dependent genes during perinatal stages of Dio2KO mice contrasts with Dio2KO mice at P15 and P21 when the expression of T3-responsive genes is not altered (Galton et al. 2007; Morte et al. 2010 ) and reinforces our present findings indicating that D2 plays a critical role in the supply of T3 mainly during early brain development. The relevance of D2 activity during cerebral cortex development was also explored when TH brain availability is altered in mice lacking the TH transporter Mct8. Special focus was placed on the contribution of D2 activity to the transient perinatal brain hyperthyroidism present in Mct8KO animals (Ferrara et al. 2013; Núñez et al. 2014) . At P3, double Mct8/Dio2KO mice presented a state of cerebral cortex hypothyroidism in contrast to single Mct8KO animals that displayed a situation of cerebral cortex hyperthyroidism. Therefore, D2 activity was found to be necessary to generate this perinatal cortical hyperthyroidism, suggesting that TH excess is not due to increased TH transport across brain barriers directly from the systemic circulation. Mct8KO mice during perinatal life manifest slight hyperthyroxinemia that could provide a relative excess of substrate to the D2, sufficient to increase T3 formation but not to increase D2 degradation. This clearly indicates that D2 provides the brain with T3; however, the role of Mct8 transporter at these stages of development still remains unknown and it cannot be ruled out that Mct8 mediates T3 efflux and/or degradation of T3 by D3, as suggested previously (Ferrara et al. 2013; Núñez et al. 2014; Stohn et al. 2016) .
One limitation of the present work is the impossibility of measuring TH levels in the fetal plasma as would be more informative about the maternal contribution of THs, which is now being inferred from the TH content in the fetal liver. Furthermore, the amount of tissue required to measure TH content in the brain by radioimmunoassay did not allow us to measure TH content in microdissected fetal brain regions, namely the cerebral cortex. TH determinations in specific cortical regions would give better insight into cerebral cortex fetal development. Also, concerning D2 activity and gene expression analyses, this study lacks cellular resolution. Nevertheless, this does not represent a problem in the evaluation of the global effects of changes in the distribution/metabolism/action of THs within the scope of the present study.
Despite these limitations, the data obtained here indicate that maternal T4 is an essential source of TH to the fetal developing brain and that fetal T3 content is regulated through the conversion of T4 into T3 by D2 activity, which is detected from embryonic stages. As well as this, the data show that during mouse fetal brain development T4 transported across the choroid plexus can be converted into T3 by D2 activity at the BCSFB and supply the brain with T3 from the LVs and that T3 generated at the meninges by D2 activity might regulate the development of the cerebral cortex. A final conclusion is that D2 activity is necessary to mediate the correct expression of T3-dependent genes in the perinatal cerebral cortex and is also necessary to generate the transient cerebral cortex hyperthyroidism in Mct8-deficient mice. Overall, our results provide the first data on the understanding of TH economy to maintain the homeostasis in the fetal and perinatal mouse cerebral cortex.
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